Anita G. Seto, Ph.D. - Publications

University of Colorado, Boulder, Boulder, CO, United States 
RNA (ribozyme) catalysis

9/26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Seto AG, Kingston RE, Lau NC. The coming of age for Piwi proteins. Molecular Cell. 26: 603-9. PMID 17560367 DOI: 10.1016/J.Molcel.2007.05.021  0.64
2006 Lau NC, Seto AG, Kim J, Kuramochi-Miyagawa S, Nakano T, Bartel DP, Kingston RE. Characterization of the piRNA complex from rat testes. Science (New York, N.Y.). 313: 363-7. PMID 16778019 DOI: 10.1126/Science.1130164  0.64
2003 Seto AG, Umansky K, Tzfati Y, Zaug AJ, Blackburn EH, Cech TR. A template-proximal RNA paired element contributes to Saccharomyces cerevisiae telomerase activity. Rna (New York, N.Y.). 9: 1323-32. PMID 14561882 DOI: 10.1261/Rna.5570803  0.8
2002 Seto AG, Livengood AJ, Tzfati Y, Blackburn EH, Cech TR. A bulged stem tethers Est1p to telomerase RNA in budding yeast. Genes & Development. 16: 2800-12. PMID 12414733 DOI: 10.1101/Gad.1029302  0.8
2001 Lively TN, Ferguson HA, Galasinski SK, Seto AG, Goodrich JA. c-Jun binds the N terminus of human TAF(II)250 to derepress RNA polymerase II transcription in vitro. The Journal of Biological Chemistry. 276: 25582-8. PMID 11316804 DOI: 10.1074/Jbc.M100278200  0.64
2001 Kim LJ, Seto AG, Nguyen TN, Goodrich JA. Human Taf(II)130 is a coactivator for NFATp. Molecular and Cellular Biology. 21: 3503-13. PMID 11313476 DOI: 10.1128/Mcb.21.10.3503-3513.2001  0.64
2000 Kim LJ, Ferguson HA, Seto AG, Goodrich JA. Characterization of DNA binding, transcriptional activation, and regulated nuclear association of recombinant human NFATp. Bmc Immunology. 1: 1. PMID 11231878 DOI: 10.1186/1471-2172-1-1  0.64
1999 Seto AG, Zaug AJ, Sobel SG, Wolin SL, Cech TR. Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle. Nature. 401: 177-80. PMID 10490028 DOI: 10.1038/43694  0.64
1997 Jacoby T, Flanagan H, Faykin A, Seto AG, Mattison C, Ota I. Two protein-tyrosine phosphatases inactivate the osmotic stress response pathway in yeast by targeting the mitogen-activated protein kinase, Hog1. The Journal of Biological Chemistry. 272: 17749-55. PMID 9211927 DOI: 10.1074/Jbc.272.28.17749  0.64
Low-probability matches
2015 Deng L, Blanco FJ, Stevens H, Lu R, Caudrillier A, McBride MW, McClure JD, Grant JS, Thomas M, Frid MG, Stenmark KR, White K, Seto AG, Morrell NW, Bradshaw AC, et al. miR-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. Circulation Research. PMID 26311719 DOI: 10.1161/CIRCRESAHA.115.306806  0.04
2013 Dickinson BA, Semus HM, Montgomery RL, Stack C, Latimer PA, Lewton SM, Lynch JM, Hullinger TG, Seto AG, van Rooij E. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. European Journal of Heart Failure. 15: 650-9. PMID 23388090 DOI: 10.1093/eurjhf/hft018  0.04
2012 Seto AG, van Rooij E. Circulating microRNAs to identify human heart failure. European Journal of Heart Failure. 14: 118-9. PMID 22253452 DOI: 10.1093/eurjhf/hfr179  0.04
2012 Hullinger TG, Montgomery RL, Seto AG, Dickinson BA, Semus HM, Lynch JM, Dalby CM, Robinson K, Stack C, Latimer PA, Hare JM, Olson EN, van Rooij E. Inhibition of miR-15 protects against cardiac ischemic injury. Circulation Research. 110: 71-81. PMID 22052914 DOI: 10.1161/Circresaha.111.244442  0.04
2011 Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation. 124: 1537-47. PMID 21900086 DOI: 10.1161/Circulationaha.111.030932  0.04
2010 Seto AG. The road toward microRNA therapeutics. The International Journal of Biochemistry & Cell Biology. 42: 1298-305. PMID 20227519 DOI: 10.1016/j.biocel.2010.03.003  0.04
2020 Anastasiadou E, Seto A, Beatty X, Hermreck M, Gilles ME, Stroopinsky D, Pinter-Brown LC, Pestano L, Marchese C, Avigan D, Trivedi P, Escolar D, Jackson A, Slack FJ. Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth and . Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33208342 DOI: 10.1158/1078-0432.CCR-20-3139  0.01
2018 Gallant-Behm CL, Piper J, Lynch JM, Seto AG, Hong SJ, Mustoe TA, Maari C, Pestano LA, Dalby CM, Jackson AL, Rubin P, Marshall WS. A microRNA-29 mimic (remlarsen) represses extracellular matrix expression and fibroplasia in the skin. The Journal of Investigative Dermatology. PMID 30472058 DOI: 10.1016/j.jid.2018.11.007  0.01
2018 Seto AG, Beatty X, Lynch JM, Hermreck M, Tetzlaff M, Duvic M, Jackson AL. Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma. British Journal of Haematology. PMID 30125933 DOI: 10.1111/bjh.15547  0.01
2018 Foss FM, Querfeld C, Kim YH, Pinter-Brown LC, William BM, Porcu P, Pacheco T, Haverkos B, DeSimone J, Guitart J, Halwani AS, Eradat HA, Huen A, Seto AG, Pestano LA, et al. Ph 1 study of MRG-106, an inhibitor of miR-155, in CTCL. Journal of Clinical Oncology. 36: 2511-2511. DOI: 10.1200/Jco.2018.36.15_Suppl.2511  0.01
2017 Eding JE, Demkes CJ, Lynch JM, Seto AG, Montgomery RL, Semus HM, Jackson AL, Isabelle M, Chimenti S, van Rooij E. The Efficacy of Cardiac Anti-miR-208a Therapy Is Stress Dependent. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28202391 DOI: 10.1016/j.ymthe.2017.01.012  0.01
2017 Foss FM, Querfeld C, Porcu P, Kim YH, Pacheco T, Halwani AS, DeSimone J, William BM, Seto AG, Ruckman J, Landry ML, Jackson AL, Pestano LA, Dickinson BA, Sanseverino M, et al. Phase 1 trial evaluating MRG-106, a synthetic inhibitor of microRNA-155, in patients with cutaneous t-cell lymphoma (CTCL). Journal of Clinical Oncology. 35: 7564-7564. DOI: 10.1200/Jco.2017.35.15_Suppl.7564  0.01
2017 Gallant-Behm C, Maari C, Jackson A, Seto A, Lynch J, Ruckman J, Landry M, Pestano L, Dickinson B, Dalby C, Sanseverino M, Rodman D, Gordon G, Rubin P, Marshall W. LB948 Pharmacodynamic activity of a microRNA-29b mimic (MRG-201) in human skin incisions Journal of Investigative Dermatology. 137: B4. DOI: 10.1016/j.jid.2017.07.022  0.01
2017 Querfeld C, Foss F, Porcu P, Kim Y, Pacheco T, Haverkos B, Halwani A, DeSimone J, William B, Pinter-Brown L, Seto A, Ruckman J, Landry M, Jackson A, Dickinson B, et al. PH 1 TRIAL EVALUATING MRG-106, A MICRORNA-155 INHIBITOR, ADMINISTERED BY INTRATUMORAL, SUBCUTANEOUS, OR INTRAVENOUS DELIVERY IN CUTANEOUS T-CELL LYMPHOMA (CTCL) PATIENTS Hematological Oncology. 35: 275-276. DOI: 10.1002/Hon.2438_149  0.01
2008 Driskell JD, Seto AG, Jones LP, Jokela S, Dluhy RA, Zhao YP, Tripp RA. Rapid microRNA (miRNA) detection and classification via surface-enhanced Raman spectroscopy (SERS). Biosensors & Bioelectronics. 24: 923-8. PMID 18799303 DOI: 10.1016/J.Bios.2008.07.060  0.01
1999 Seto AG, Zaug AJ, Sobel SG, Wolin SL, Cech TR. erratum: Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle Nature. 402: 898-898. DOI: 10.1038/47284  0.01
1994 Dadoo R, Seto AG, Colón LA, Zare RN. End-column chemiluminescence detector for capillary electrophoresis Analytical Chemistry. 66: 303-306. DOI: 10.1021/Ac00074A020  0.01
Hide low-probability matches.